Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Applied DNA Sciences, Inc. (NASDAQ: APDN).

Full DD Report for APDN

You must become a subscriber to view this report.


Recent News from (NASDAQ: APDN)

Applied DNA Signs Joint Development Agreement with Everledger to Develop and Market a CertainT®-Enhanced, Blockchain-Based Platform for Provenance Verification
CertainT provides physical identity and authentication to assets tracked through complex supply chains on the Everledger platform Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA,” “the Company”), a leader in large-scale PCR-based DNA manufacturing,...
Source: Business Wire
Date: December, 10 2018 05:00
Applied DNA Subsidiary LineaRx Provides Cost and Quality Advantages to Technogenetics Diagnostic Solutions
Large-Scale Production of Linear DNA Shows the Best Lot-To-Lot Reproducibility and Sequence Accuracy for Kits Targeting Autoimmunity and Infectious Diseases Applied DNA Sciences Inc. (NASDAQ:APDN) (“Applied DNA”), the leader in large-scale PCR-based DNA manufacturing, an...
Source: Business Wire
Date: November, 07 2018 08:30
New Study: DNA Molecular Tagging is an Effective Tool to Authenticate Denim, One of the Toughest Fabrics
Results Suggest that DNA Tagging can be Applied to other Premier Fibers for Field-to-Finished-Garment Authentication Results of a new study published in the September/October 2018 issue of the AATCC Review confirmed that DNA molecular tagging is an effective tool to authenticate denim...
Source: Business Wire
Date: November, 05 2018 08:30
GHCL, a Global Home Textiles Player, Creates "CIRKULARITY", a Brand Platform, Inspired By "REKOOP" Sustainable, Traceable, Recycled Polyester Bedding
“REKOOP” is the first Bedding solution to use Applied DNA’s CertainT Platform and Reliance Industries’ Recron GreenGold fiber for source verification and traceability of recycled polyester across the supply chain; Arrives in US Q1 2019 Global manufacturer of ...
Source: Business Wire
Date: October, 29 2018 05:00
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
Collaboration Seeks to Develop PCR-produced Linear DNA as a Safer Expression Vector for Vaccines Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced today that LineaRx, Inc. (“LineaRx”), its wholly-owned subsi...
Source: Business Wire
Date: September, 20 2018 05:00
Applied DNA Announces $1.65 Million Private Placement of Secured Convertible Notes
Applied DNA Sciences Inc., (NASDAQ: APDN, “Applied DNA” or the “Company”), the leader in large-scale PCR-based DNA manufacturing, today announced the closing in the amount of $1.65 million of secured convertible notes (the “Notes”) by way of a non-...
Source: Business Wire
Date: September, 04 2018 05:00
Applied DNA Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit
High-Expression Amplicons Facilitate Non-Recombinant Gene Therapies. Hold the Potential to Serve as an Alternative to Plasmids and Viral Vectors. Applied DNA Sciences Inc., (NASDAQ: APDN, “Applied DNA,”), the leader in large-scale PCR-based DNA manufacturing, will pres...
Source: Business Wire
Date: August, 27 2018 05:00
Technology - Top 5 Gainers / Losers as of 2.55 PM (08/14/2018)
Gainers:  MXWL +18% . BBOX +13% . DBD +13% . TAOP +10% . OTEL +10% . More news on: Maxwell Technologies, Inc., Black Box Corporation, Diebold Nixdorf, Tech stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 14 2018 14:55
Midday Gainers / Losers (08/14/2018)
Gainers: THST +50% . LEVB +21% . HYRE +21% . LAC +19% . XERS +15% . TAOP +15% . TPR +14% . SVT +14% . XOMA +13% . IDRA +13% . More news on: Truett-Hurst, Inc., Level Brands, Inc., HyreCar, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 14 2018 12:50
FQ3 miss pressures Applied DNA Sciences, down 23%
Thinly traded nano cap Applied DNA Sciences ( APDN -22.7% ) slumps on almost a 5x surge in volume, albeit on turnover of only 221K shares, after posting fiscal Q3 numbers  after the close yesterday that were shy of expectations. More news on: Applied DNA Sciences, Inc., Healthcare ...
Source: SeekingAlpha
Date: August, 14 2018 12:38

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-131.130.99991.130.977221,539
2018-12-121.071.131.1651.06277,959
2018-12-111.051.08461.11991.0553,574
2018-12-101.101.031.10991.02306,785
2018-12-071.061.0811.101.0439,539

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1331,82779,66339.9520Short
2018-12-1255,16091,46360.3085Short
2018-12-1117,11940,84541.9121Short
2018-12-10110,532158,96069.5345Short
2018-12-0724,86730,07782.6778Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on APDN.


About Applied DNA Sciences, Inc. (NASDAQ: APDN)

Logo for Applied DNA Sciences, Inc. (NASDAQ: APDN)

Applied DNA Sciences APDN is the only company in the world that is making use of the complex codes embedded in botanical DNA as the ultimate solution to counterfeiting, supply chain defense, perpetrator marking, tactical forensic systems, and a growing range of other unbreakable authentication programs.

 

Contact Information

 

 

Current Management

  • James A. Hayward / CEO
  • Karol Gray / CFO
  • Benjamin Liang / CTO
  • Debbie Bailey / Director, Inv. Rel.
  • John Bitzer, III /
  • Charles Ryan /
  • Yacov Shamash /
  • Sanford Simon /

Current Share Structure

  • Market Cap: $46,372,568 - 03/20/2018
  • Issue and Outstanding: 30,112,057 - 12/22/2017

 


Recent Filings from (NASDAQ: APDN)

Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: May, 07 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: May, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 28 2018

 

 


Daily Technical Chart for (NASDAQ: APDN)

Daily Technical Chart for (NASDAQ: APDN)


Stay tuned for daily updates and more on (NASDAQ: APDN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: APDN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in APDN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of APDN and does not buy, sell, or trade any shares of APDN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/